Navigation Links
Preliminary new blood test to detect Alzheimer's disease uncovered
Date:2/11/2011

DALLAS Feb. 14, 2011 UT Southwestern Medical Center scientists have helped develop a novel technology to diagnose Alzheimer's disease from blood samples long before symptoms appear.

This preliminary technology, which uses synthetic molecules to seek out and identify disease-specific antibodies, also could be used eventually in the development of specific biomarkers for a range of other hard-to-diagnose diseases and conditions, including Parkinson's disease and immune system-related diseases like multiple sclerosis and lupus, the researchers predict.

"One of the great challenges in treating patients with Alzheimer's disease is that once symptoms appear, it's too late. You can't un-ring the bell," said Dr. Dwight German, professor of psychiatry and an author of the paper published in the Jan. 7 edition of Cell. "If we can find a way to detect the disease in its earliest stages before cognitive impairment begins we might be able to stop it in its tracks by developing new treatment strategies."

Because patients with Alzheimer's disease (AD) exhibit immune system activation and neurodegeneration in several brain regions, researchers in the study hypothesized that there may be numerous antibodies in the serum of affected patients that are specific to the disease and can serve as a biomarker.

Antigens substances such as protein from a virus or bacteria that triggers an immune response traditionally have been necessary for the discovery of antibody biomarkers. It has been impossible previously to identify an antibody (a type of targeted immune molecule) without first knowing the antigen that triggers its production.

The new study, however, challenges conventional wisdom and uses synthetic molecules (peptoids) rather than antigens to successfully detect signs of disease in patients' blood samples. These peptoids have many advantages; they can be modified easily and can be produced quickly in relatively large amounts at lower cost.

The adaptive immune system is thought to be a rich source of protein biomarkers, but diagnostically useful antibodies remain undiscovered for a large number of diseases, Dr. German said. This is, in part, because the antigens that trigger an immune response in many diseases are unknown. The technology behind this discovery is essentially an immune-system reader, which is designed to pick out antibodies without knowing in advance which ones to look for.

The researchers used a combination library of several thousand peptoids to screen serum samples from mice with multiple sclerosis-like symptoms as well as from healthy control mice. The particular peptoids that retained more antibodies from the blood samples of the diseased animals were identified as potential agents for capturing diagnostically useful molecules.

The investigators then examined serum samples from six AD patients, six healthy patients and six patients with Parkinson's. Three peptoids were identified that captured six times the IgG antibody levels in all of the Alzheimer's patients when compared to the control group or to the Parkinson's patients. Two of the peptoids were found to bind the same IgG antibody, while the third was shown to bind to different antibodies meaning there are at least two candidate biomarkers for AD. Using an additional set of 16 normal control subjects and 10 subjects at the very early state of AD, the three candidate biomarkers identified AD with 90 percent accuracy.

"The results of this study, though preliminary, show great potential for becoming a landmark," said Dr. German.


'/>"/>

Contact: Rachel Skei Donihoo
rachel.donihoo@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Related medicine news :

1. Preliminary highlights of the AAPM 52nd Annual Meeting, Philadelphia, Pa., July 18-22, 2010
2. Quincy Bioscience Announces Encouraging Preliminary Results of Randomized, Double-Blind, Placebo-Controlled Memory Study
3. GSI Group Reports Preliminary Fourth Quarter 2009 Bookings, and Cash Balance
4. Need for Blood and Organ Donors Continues to Grow
5. Lead Exposure May Raise Blood Pressure in Pregnancy
6. Early infusion of donor T cells prevents graft versus host disease in blood cancer patients
7. Researchers Craft Blood Vessels for Heart, Kidney Patients
8. New nanoparticles make blood clots visible
9. Shoo fly: Catnip oil repels bloodsucking flies
10. Researchers discover root cause of blood vessel damage in diabetes
11. Blood Protein Level May Not Influence Effectiveness of Statins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... , ... This week the The Voss Law Firm celebrates 14 years as ... firm grew quickly and has built a reputation for excellence, trust, and accountability. Now ... they deserve from their insurance companies. , The Voss Law Firm is dedicated ...
(Date:8/23/2017)... ... 23, 2017 , ... Drs. Steven White and Brad Haines are pleased to ... advantage of this offer, valued at more than $300 per year, new patients can ... dentist, patients receive a complimentary professional whitening procedure. , Stained or yellowed tooth ...
(Date:8/23/2017)... ... 2017 , ... Based on worldwide research and decades of ... in treating and helping to heal addictions and substance abuse disorders. The TreatNOW ... the wounds to the brain from traumatic brain injuries, and the brain injuries ...
(Date:8/23/2017)... Fairfax, VA (PRWEB) , ... August 23, 2017 , ... The Stevie® Awards have announced ... International Business Awards , the world’s premier business awards competition. , Nominees in the 2017 ... were determined by a points system based on the total number of awards won in ...
(Date:8/23/2017)... , ... August 23, 2017 , ... ... healthcare industry, made the 2017 Inc. 5000 with a three-year sales growth ... nation’s fastest-growing private companies and comprises the most comprehensive look at America’s independent ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017   Marshall County Hospital in Benton, ... proactively reduce the risk of hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , ... energy to kill deadly pathogens such as C. diff , MRSA, MERS, Ebola and ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/2/2017)... CaryRx, a next-generation full-service pharmacy, has announced the launch of ... Washington D.C. metropolitan area. CaryRx aims ... medications through the convenience of its patient-friendly mobile app. Prescriptions ... hour to any location in D.C. ... to Washington D.C. ," says Areo Nazari ...
(Date:7/31/2017)... 31, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), has been ... Michigan by Crain,s Detroit Business . ... companies by three-year revenue growth. This year,s edition measures growth ... To view the complete list, visit crainsdetroit.com/awards/fast_50/2017 .  ... incredible triumph," said Phil Hagerman , CEO and chairman ...
Breaking Medicine Technology: